Pub Date : 2023-01-01DOI: 10.32364/2618-8430-2023-6-2-78-87
I. G. Kutsenko, I. O. Borovikov, E. I. Kravtsova, S. K. Batmen, A. S. Magay, O. I. Borovikova, V. A. Avakimyan, A. A. Andreeva
Aim: to perform a comparative analysis of clinical and microbiological efficacy and compliance to treatment with 5-nitroimidazole derivatives in patients with bacterial vaginosis (BV). Patients and Methods: this prospective open randomized study included 96 patients diagnosed with BV. The patients were divided into two groups: group 1 (n=48) received antimicrobials — oral secnidazole 2000 mg in a single dose (decontamination therapy) and vaginally administered L. casei rhamnosus Doderleini for 14 days to restore the vaginal flora (contamination therapy); group 2 (n=48) received oral metronidazole 500 mg twice daily for 7 days (decontamination therapy) and vaginally administered L. casei rhamnosus Doderleini for 14 days (contamination therapy). Clinical efficacy was evaluated one and six months after the end of therapy. The treatment efficacy criteria included the absence of specific patient's complaints, clinical and laboratory findings (pH; Nugent score), and PCR results. The compliance to treatment was assessed using clinical and psychological tests (the Morisky-Green Scale and the Modified Medication Compliance Scale). The assessment of safety profile was based on the analysis of adverse events (AE). Results: one month after the end of treatment all patients had a statistically significant (p<0.05) reduction in the prevalence of BV symptoms (unpleasant vaginal odor, pathological vaginal discharge, itching, dyspareunia, dysuria events) as compared to those at the baseline. At month 1 after the end of treatment, subgroup analysis did not demonstrate a significant difference. Six months after the end of treatment the proportion of the group 1 patients who had pathological vaginal discharge with specific odor increased to 16.7%, while in the group 2 patients it reduced to 8.3% (p<0.05). Microbiological assessment (PCR) of the combination therapy in two groups of patients with BV demonstrated a high antibacterial efficacy of 5-nitroimidazole derivatives during the first month of follow-up. The patients were considered fully compliant if they scored 4 on the Morisky — Green Scale and scored 30 on the Modified Medication Compliance Scale of V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology. The percentage of full compliance was 76.2±2.8% in the group 1 patients and 93.75±3.25% in the group 2 patients. Conclusion: a high comparative clinical and microbiological effectiveness of treatments with 5-nitroimidazole derivatives (metronidazole and secnidazole) with further vaginal colonization with lactobacilli was demonstrated in patients with bacterial vaginosis. Full medication compliance was higher in patients receiving secnidazole for BV treatment. KEYWORDS: bacterial vaginosis, vaginal microbiota, vaginal discharge, 5-nitroimidazole derivatives, metronidazole, secnidazole, compliance. FOR CITATION: Kutsenko I.G., Borovikov I.O., Kravtsova E.I. et al. Bacterial vaginosis: comparative effectiveness of treatments with 5-nitroimi
{"title":"Bacterial vaginosis: comparative effectiveness of treatments with 5-nitroimidazole derivatives","authors":"I. G. Kutsenko, I. O. Borovikov, E. I. Kravtsova, S. K. Batmen, A. S. Magay, O. I. Borovikova, V. A. Avakimyan, A. A. Andreeva","doi":"10.32364/2618-8430-2023-6-2-78-87","DOIUrl":"https://doi.org/10.32364/2618-8430-2023-6-2-78-87","url":null,"abstract":"Aim: to perform a comparative analysis of clinical and microbiological efficacy and compliance to treatment with 5-nitroimidazole derivatives in patients with bacterial vaginosis (BV). Patients and Methods: this prospective open randomized study included 96 patients diagnosed with BV. The patients were divided into two groups: group 1 (n=48) received antimicrobials — oral secnidazole 2000 mg in a single dose (decontamination therapy) and vaginally administered L. casei rhamnosus Doderleini for 14 days to restore the vaginal flora (contamination therapy); group 2 (n=48) received oral metronidazole 500 mg twice daily for 7 days (decontamination therapy) and vaginally administered L. casei rhamnosus Doderleini for 14 days (contamination therapy). Clinical efficacy was evaluated one and six months after the end of therapy. The treatment efficacy criteria included the absence of specific patient's complaints, clinical and laboratory findings (pH; Nugent score), and PCR results. The compliance to treatment was assessed using clinical and psychological tests (the Morisky-Green Scale and the Modified Medication Compliance Scale). The assessment of safety profile was based on the analysis of adverse events (AE). Results: one month after the end of treatment all patients had a statistically significant (p<0.05) reduction in the prevalence of BV symptoms (unpleasant vaginal odor, pathological vaginal discharge, itching, dyspareunia, dysuria events) as compared to those at the baseline. At month 1 after the end of treatment, subgroup analysis did not demonstrate a significant difference. Six months after the end of treatment the proportion of the group 1 patients who had pathological vaginal discharge with specific odor increased to 16.7%, while in the group 2 patients it reduced to 8.3% (p<0.05). Microbiological assessment (PCR) of the combination therapy in two groups of patients with BV demonstrated a high antibacterial efficacy of 5-nitroimidazole derivatives during the first month of follow-up. The patients were considered fully compliant if they scored 4 on the Morisky — Green Scale and scored 30 on the Modified Medication Compliance Scale of V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology. The percentage of full compliance was 76.2±2.8% in the group 1 patients and 93.75±3.25% in the group 2 patients. Conclusion: a high comparative clinical and microbiological effectiveness of treatments with 5-nitroimidazole derivatives (metronidazole and secnidazole) with further vaginal colonization with lactobacilli was demonstrated in patients with bacterial vaginosis. Full medication compliance was higher in patients receiving secnidazole for BV treatment. KEYWORDS: bacterial vaginosis, vaginal microbiota, vaginal discharge, 5-nitroimidazole derivatives, metronidazole, secnidazole, compliance. FOR CITATION: Kutsenko I.G., Borovikov I.O., Kravtsova E.I. et al. Bacterial vaginosis: comparative effectiveness of treatments with 5-nitroimi","PeriodicalId":34075,"journal":{"name":"RMZh Mat'' i ditia","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69553875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Destructive pneumonia (DP) in children is a complication derived from community-acquired pneumonia, while parenchymal necrosis occurs in the pulmonary infiltration zone with the formation of multiple merging small cavities. The disease pathogenesis has not yet been precisely established. The factors predisposing to pulmonary destructive complications in pneumonia remain unknown. We present a case study of this disease in a 5-year-old female patient hospitalized in December 2022. Manifestation in the form of acute upper respiratory tract infection, subsequent deterioration with the progression of pneumonia and pleurisy indicate the importance of viral-bacterial interactions in the DP pathogenesis. Influenza A was confirmed in the laboratory, while Streptococcus pneumoniae was isolated in the fluid culture obtained during bronchoalveolar lavage. Using the example of the presented case, we discuss the mechanisms of DP pathogenesis in children from a modern perspective. The necessity of coagulology, a combination of radiology diagnostic methods (radiography, ultrasound, computed tomography) was justified. It is necessary to further study the pathogenetic mechanisms of the DP progression in order to optimize preventive and therapeutic rehabilitation measures in community-acquired pneumonia in children. KEYWORDS: destructive pneumonia, necrotizing pneumonia, influenza A, Streptococcus pneumoniae, hypercoagulation. FOR CITATION: Tolstova E.M., Besedina M.V., Zaytseva O.V., Zaitseva N.S., Yatsyshina S.B., Khaspekov D.V., Olkhova E.B., Turishchev I.V., Sholokhova N.A., Galeev P.P., Belyaeva T.Yu. Pathogenetic mechanisms of destructive pneumonia in children. Case report with literature review. Russian Journal of Woman and Child Health. 2023;6(3):310–319 (in Russ.). DOI: 10.32364/2618-8430-2023-6-3-15.
{"title":"Pathogenetic mechanisms of destructive pneumonia in children. Case report with literature review","authors":"E.M. Tolstova, M.V. Besedina, O.V. Zaytseva, N.S. Zaitseva, S.B. Yatsyshina, D.V. Khaspekov, E.B. Olkhova, I.V. Turishchev, N.A. Sholokhova, P.P. Galeev, T.Yu. Belyaeva","doi":"10.32364/2618-8430-2023-6-3-15","DOIUrl":"https://doi.org/10.32364/2618-8430-2023-6-3-15","url":null,"abstract":"Destructive pneumonia (DP) in children is a complication derived from community-acquired pneumonia, while parenchymal necrosis occurs in the pulmonary infiltration zone with the formation of multiple merging small cavities. The disease pathogenesis has not yet been precisely established. The factors predisposing to pulmonary destructive complications in pneumonia remain unknown. We present a case study of this disease in a 5-year-old female patient hospitalized in December 2022. Manifestation in the form of acute upper respiratory tract infection, subsequent deterioration with the progression of pneumonia and pleurisy indicate the importance of viral-bacterial interactions in the DP pathogenesis. Influenza A was confirmed in the laboratory, while Streptococcus pneumoniae was isolated in the fluid culture obtained during bronchoalveolar lavage. Using the example of the presented case, we discuss the mechanisms of DP pathogenesis in children from a modern perspective. The necessity of coagulology, a combination of radiology diagnostic methods (radiography, ultrasound, computed tomography) was justified. It is necessary to further study the pathogenetic mechanisms of the DP progression in order to optimize preventive and therapeutic rehabilitation measures in community-acquired pneumonia in children. KEYWORDS: destructive pneumonia, necrotizing pneumonia, influenza A, Streptococcus pneumoniae, hypercoagulation. FOR CITATION: Tolstova E.M., Besedina M.V., Zaytseva O.V., Zaitseva N.S., Yatsyshina S.B., Khaspekov D.V., Olkhova E.B., Turishchev I.V., Sholokhova N.A., Galeev P.P., Belyaeva T.Yu. Pathogenetic mechanisms of destructive pneumonia in children. Case report with literature review. Russian Journal of Woman and Child Health. 2023;6(3):310–319 (in Russ.). DOI: 10.32364/2618-8430-2023-6-3-15.","PeriodicalId":34075,"journal":{"name":"RMZh Mat'' i ditia","volume":"61 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135010061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.32364/2618-8430-2023-6-1-50-59
A. Zaplatnikov, A. Girina, E. Burtseva, I. V. Lepiseva, I. D. Maykova, V. I. Svintsitskaya, M. Leshik, N. Koroid, N. F. Dubovets
The article is focused on the issues of immunoprophylaxis and immunotherapy of acute, recurrent and repeat respiratory infections in children. The authors underscore the high efficacy of active specific immunoprophylaxis against influenza virus, pneumococcal and Hib-infections. They emphasize that the use of combined immunoprophylaxis (vaccine + non-specific immunoprophylactic agents) is effective for achieving the maximal preventive effect, especially in children with recurrent and repeat respiratory infections. The article elucidates such issues as the mode of action and the efficacy of therapy and prevention, as well as the tolerability and safety of topical bacterial lysates in pediatric practice. It also reviews the pathogenetic rationale of using topical bacterial lysate IRS 19 in the prevention and treatment of acute, recurrent and repeat respiratory infections in children. The authors highlight the beneficial therapeutic effects of topical bacterial lysate Imudon on the clinical course of infectious and inflammatory oropharyngeal diseases and its preventive action. The authors outline the good tolerability of topical bacterial lysates used in pediatric practice. Taking into consideration that achievement of the most effective prevention of acute respiratory infections (ARI) in children with recurrent and repeat respiratory infections is possible via combination of immunizations, whereas topical bacterial lysates can be applied successfully as non-specific immunoprophylactic agents. KEYWORDS: vaccination, influenza, children, immunity, immunotherapy, immunoprophylaxis, acute respiratory infections, recurrent respiratory infections, repeat respiratory infections, topical bacterial lysates, trained immunity, frequently ill children. FOR CITATION: Zaplatnikov A.L., Girina A.A., Burtseva E.I. et al. Acute, recurrent and repeat respiratory infections in children: the issues of immunoprophylaxis and immunotherapy. Russian Journal of Woman and Child Health. 2023;6(1):50–59 (in Russ.). DOI: 10.32364/2618- 8430-2023-6-1-50-59.
{"title":"Acute, recurrent and repeat respiratory infections in children: the issues of immunoprophylaxis and immunotherapy","authors":"A. Zaplatnikov, A. Girina, E. Burtseva, I. V. Lepiseva, I. D. Maykova, V. I. Svintsitskaya, M. Leshik, N. Koroid, N. F. Dubovets","doi":"10.32364/2618-8430-2023-6-1-50-59","DOIUrl":"https://doi.org/10.32364/2618-8430-2023-6-1-50-59","url":null,"abstract":"The article is focused on the issues of immunoprophylaxis and immunotherapy of acute, recurrent and repeat respiratory infections in children. The authors underscore the high efficacy of active specific immunoprophylaxis against influenza virus, pneumococcal and Hib-infections. They emphasize that the use of combined immunoprophylaxis (vaccine + non-specific immunoprophylactic agents) is effective for achieving the maximal preventive effect, especially in children with recurrent and repeat respiratory infections. The article elucidates such issues as the mode of action and the efficacy of therapy and prevention, as well as the tolerability and safety of topical bacterial lysates in pediatric practice. It also reviews the pathogenetic rationale of using topical bacterial lysate IRS 19 in the prevention and treatment of acute, recurrent and repeat respiratory infections in children. The authors highlight the beneficial therapeutic effects of topical bacterial lysate Imudon on the clinical course of infectious and inflammatory oropharyngeal diseases and its preventive action. The authors outline the good tolerability of topical bacterial lysates used in pediatric practice. Taking into consideration that achievement of the most effective prevention of acute respiratory infections (ARI) in children with recurrent and repeat respiratory infections is possible via combination of immunizations, whereas topical bacterial lysates can be applied successfully as non-specific immunoprophylactic agents. KEYWORDS: vaccination, influenza, children, immunity, immunotherapy, immunoprophylaxis, acute respiratory infections, recurrent respiratory infections, repeat respiratory infections, topical bacterial lysates, trained immunity, frequently ill children. FOR CITATION: Zaplatnikov A.L., Girina A.A., Burtseva E.I. et al. Acute, recurrent and repeat respiratory infections in children: the issues of immunoprophylaxis and immunotherapy. Russian Journal of Woman and Child Health. 2023;6(1):50–59 (in Russ.). DOI: 10.32364/2618- 8430-2023-6-1-50-59.","PeriodicalId":34075,"journal":{"name":"RMZh Mat'' i ditia","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69552161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-01-01DOI: 10.32364/2618-8430-2023-6-1-6-12
S. Kalashnikov, A. G. Konoplyannikov, K.Yu. Voskoboeva, L.R. Semenova, I. S. Kulakova
Aim: to evaluate the course and outcomes of monochorial monoamniotic (MCMA) twin pregnancy. Patients and Methods: this prospective study included 34 patients (a mean age 31.8±4.3 years) with MCMA twins for assessing the course of pregnancy and perinatal outcomes. The authors evaluated such criteria as the timing of delivery and the prenatal management of MCMA-twin pregnancy, as well as the perinatal outcomes and mortality. Monitoring of the pregnant women with umbilical cord entanglement was started at 16 weeks of gestation and included ultrasound examination every two weeks and after 26–28 weeks of gestation — two or three times a week coupled with cardiotocography for fetal assessment. Results: the study demonstrated a high prevalence of cervical insufficiency which was found in 10 (29.4%) MCMA twin pregnancies at 18 to 28 weeks of gestation. The diagnosis of umbilical cord entanglement was established in 16 (47.1%) patients, twin-twin transfusion syndrome (TTTS) – in 2 (5.9%) patients, and twin anemia-polycythemia syndrome (TAPS) – in 1 (2.9%) patient. The reported antenatal losses were 6 of 68 (8.8%) of fetuses. There were 7 perinatal losses of 68 MCMA-twin pregnancies (10.3%). The antenatal and perinatal losses in MCMA twins were caused by the following specific complications: TTTS, cord entanglement and hypoxia due to the selective intrauterine growth restriction (sIUGR). A preterm operative delivery was used in 29 (85.2%) patients with MCMA twins. Five (14.7%) patients did not have complications and it was possible to prolong the pregnancy to 36 weeks. Caesarean sections were carried out almost for all the pregnant women (33 (97.1%)). Conclusion: the antenatal and perinatal losses in MCMA twins are caused by the specific complications. These findings prove that patients with complicated MCMA twin pregnancies need to have a careful monitoring in Level III perinatal centers. Planned caesarean sections are recommended for all MCMA twin pregnancies. If complications are detected, a preterm operative delivery closer to week 35 of gestation will enable to increase the fetal survival rates and thus to improve the perinatal outcomes. Uncomplicated MCMA twin pregnancies can be prolonged to week 36 for improving the condition of newborn babies at the time of delivery. KEYWORDS: multifetal pregnancy, monochorial monoamniotic twin pregnancy, umbilical cord entanglement, neonatal outcome, twin-twin transfusion syndrome, selective intrauterine growth restriction, twin anemia-polycythemia syndrome. FOR CITATION: Kalashnikov S.A., Konoplyannikov A.G., Voskoboeva K.Yu. et al. The course and outcomes of monochorial monoamniotic twin pregnancy. Russian Journal of Woman and Child Health. 2023;6(1):6–12 (in Russ.). DOI: 10.32364/2618-8430-2023-6-1-6-12.
{"title":"The course and outcomes of monochorial monoamniotic twin pregnancy","authors":"S. Kalashnikov, A. G. Konoplyannikov, K.Yu. Voskoboeva, L.R. Semenova, I. S. Kulakova","doi":"10.32364/2618-8430-2023-6-1-6-12","DOIUrl":"https://doi.org/10.32364/2618-8430-2023-6-1-6-12","url":null,"abstract":"Aim: to evaluate the course and outcomes of monochorial monoamniotic (MCMA) twin pregnancy. Patients and Methods: this prospective study included 34 patients (a mean age 31.8±4.3 years) with MCMA twins for assessing the course of pregnancy and perinatal outcomes. The authors evaluated such criteria as the timing of delivery and the prenatal management of MCMA-twin pregnancy, as well as the perinatal outcomes and mortality. Monitoring of the pregnant women with umbilical cord entanglement was started at 16 weeks of gestation and included ultrasound examination every two weeks and after 26–28 weeks of gestation — two or three times a week coupled with cardiotocography for fetal assessment. Results: the study demonstrated a high prevalence of cervical insufficiency which was found in 10 (29.4%) MCMA twin pregnancies at 18 to 28 weeks of gestation. The diagnosis of umbilical cord entanglement was established in 16 (47.1%) patients, twin-twin transfusion syndrome (TTTS) – in 2 (5.9%) patients, and twin anemia-polycythemia syndrome (TAPS) – in 1 (2.9%) patient. The reported antenatal losses were 6 of 68 (8.8%) of fetuses. There were 7 perinatal losses of 68 MCMA-twin pregnancies (10.3%). The antenatal and perinatal losses in MCMA twins were caused by the following specific complications: TTTS, cord entanglement and hypoxia due to the selective intrauterine growth restriction (sIUGR). A preterm operative delivery was used in 29 (85.2%) patients with MCMA twins. Five (14.7%) patients did not have complications and it was possible to prolong the pregnancy to 36 weeks. Caesarean sections were carried out almost for all the pregnant women (33 (97.1%)). Conclusion: the antenatal and perinatal losses in MCMA twins are caused by the specific complications. These findings prove that patients with complicated MCMA twin pregnancies need to have a careful monitoring in Level III perinatal centers. Planned caesarean sections are recommended for all MCMA twin pregnancies. If complications are detected, a preterm operative delivery closer to week 35 of gestation will enable to increase the fetal survival rates and thus to improve the perinatal outcomes. Uncomplicated MCMA twin pregnancies can be prolonged to week 36 for improving the condition of newborn babies at the time of delivery. KEYWORDS: multifetal pregnancy, monochorial monoamniotic twin pregnancy, umbilical cord entanglement, neonatal outcome, twin-twin transfusion syndrome, selective intrauterine growth restriction, twin anemia-polycythemia syndrome. FOR CITATION: Kalashnikov S.A., Konoplyannikov A.G., Voskoboeva K.Yu. et al. The course and outcomes of monochorial monoamniotic twin pregnancy. Russian Journal of Woman and Child Health. 2023;6(1):6–12 (in Russ.). DOI: 10.32364/2618-8430-2023-6-1-6-12.","PeriodicalId":34075,"journal":{"name":"RMZh Mat'' i ditia","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69552173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The article presents the author's experience concerning laparoscopic ovarian drilling (LOD) in women with infertility associated with polycystic ovary syndrome (PCOS). The study included 23 female patients aged 18–35 years with infertility associated with PCOS, who were treated with clomiphene citrate for 6 months without effect. All patients underwent LOD with electrocoagulation. The follow-up period after surgery was 3 years. Pregnancy occurred in 10 (43.5%) of the female patients within a year after the LOD, and in 13 (56.5%) — pregnancy occurred within 2–3 years. There was a difference in the pregnancy frequency during the year between female patients under 30 y.o. (9 (39.2%)) and over 30 y.o. (11 (47.8%)). Pregnancy occurred less frequently in patients over 30, however, due to the small number of patients, the presented results were not statistically significant. Thus, it requires further follow-up and confirmation of this conclusion. It was also revealed that the shorter the infertility duration, the greater the pregnancy likelihood after surgical treatment: pregnancy occurred in 9 (39.2%) female patients with infertility period of <3 years versus 1 (4.3%) female patient with infertility period of >3 years (RR 5.8, 95% CI 1.2–36.2). In conclusion, LOD can be used in female patients with resistance to clomiphene citrate. The ovulation restoration, and pregnancy and childbirth onset make LDL a possible alternative method of treatment with a lower risk of complications (ovarian hyperstimulation syndrome, multiple pregnancy). KEYWORDS: infertility, pregnancy, treatment, laparoscopic ovarian drilling, polycystic ovary syndrome, gonadotropin resistance. FOR CITATION: Dobrokhotova Yu.E., Grishin I.I., Ogede O.R., Ilyina I.Yu. Experience of laparoscopic ovarian drilling in the treatment of infertility associated with polycystic ovary syndrome in women. Russian Journal of Woman and Child Health. 2023;6(3):265–269 (in Russ.). DOI: 10.32364/2618-8430-2023-6-3-8.
本文介绍了腹腔镜卵巢钻孔(LOD)治疗多囊卵巢综合征(PCOS)不孕妇女的经验。研究纳入23例年龄在18-35岁的女性多囊卵巢综合征(PCOS)不孕患者，接受枸橼酸克罗米芬治疗6个月无效果。所有患者均行电凝LOD。术后随访3年。10例(43.5%)女性患者术后1年内发生妊娠，13例(56.5%)女性患者术后2 ~ 3年内发生妊娠。30岁以下女性患者妊娠频次为9例(39.2%)，30岁以上女性患者为11例(47.8%)。30岁以上患者妊娠发生率较低，但由于患者数量少，本研究结果无统计学意义。因此，这一结论需要进一步的后续行动和确认。不孕症持续时间越短，手术后妊娠可能性越大:9例(39.2%)女性不孕症3年患者发生妊娠，1例(4.3%)女性不孕症3年患者发生妊娠(RR 5.8, 95% CI 1.2 ~ 36.2)。综上所述，LOD可用于枸橼酸克罗米芬耐药女性患者。排卵恢复，妊娠和分娩的开始使LDL成为一种可能的替代治疗方法，其并发症(卵巢过度刺激综合征，多胎妊娠)的风险较低。关键词:不孕症，妊娠，治疗，腹腔镜卵巢钻孔，多囊卵巢综合征，促性腺激素抵抗。引文:Dobrokhotova Yu.E。， Grishin I.I.， Ogede o .， Ilyina I.Yu。腹腔镜卵巢钻孔治疗女性多囊卵巢综合征不孕症的体会。俄罗斯妇女与儿童健康杂志。2023;6(3):265-269。DOI: 10.32364 / 2618-8430-2023-6-3-8。
{"title":"Experience of laparoscopic ovarian drilling in the treatment of infertility associated with polycystic ovary syndrome in women","authors":"Yu.E. Dobrokhotova, I.I. Grishin, O.R. Ogede, I.Yu. Ilyina","doi":"10.32364/2618-8430-2023-6-3-8","DOIUrl":"https://doi.org/10.32364/2618-8430-2023-6-3-8","url":null,"abstract":"The article presents the author's experience concerning laparoscopic ovarian drilling (LOD) in women with infertility associated with polycystic ovary syndrome (PCOS). The study included 23 female patients aged 18–35 years with infertility associated with PCOS, who were treated with clomiphene citrate for 6 months without effect. All patients underwent LOD with electrocoagulation. The follow-up period after surgery was 3 years. Pregnancy occurred in 10 (43.5%) of the female patients within a year after the LOD, and in 13 (56.5%) — pregnancy occurred within 2–3 years. There was a difference in the pregnancy frequency during the year between female patients under 30 y.o. (9 (39.2%)) and over 30 y.o. (11 (47.8%)). Pregnancy occurred less frequently in patients over 30, however, due to the small number of patients, the presented results were not statistically significant. Thus, it requires further follow-up and confirmation of this conclusion. It was also revealed that the shorter the infertility duration, the greater the pregnancy likelihood after surgical treatment: pregnancy occurred in 9 (39.2%) female patients with infertility period of <3 years versus 1 (4.3%) female patient with infertility period of >3 years (RR 5.8, 95% CI 1.2–36.2). In conclusion, LOD can be used in female patients with resistance to clomiphene citrate. The ovulation restoration, and pregnancy and childbirth onset make LDL a possible alternative method of treatment with a lower risk of complications (ovarian hyperstimulation syndrome, multiple pregnancy). KEYWORDS: infertility, pregnancy, treatment, laparoscopic ovarian drilling, polycystic ovary syndrome, gonadotropin resistance. FOR CITATION: Dobrokhotova Yu.E., Grishin I.I., Ogede O.R., Ilyina I.Yu. Experience of laparoscopic ovarian drilling in the treatment of infertility associated with polycystic ovary syndrome in women. Russian Journal of Woman and Child Health. 2023;6(3):265–269 (in Russ.). DOI: 10.32364/2618-8430-2023-6-3-8.","PeriodicalId":34075,"journal":{"name":"RMZh Mat'' i ditia","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135007774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.32364/2618-8430-2022-5-1-18-27
I. N. Kononova, E. Kareva, Y. Dobrokhotova
To review up-to-date management algorithms for iron and folic acid deficiency in women of reproductive age, we selected relevant publications in the PubMed and Google Scholar databases (2012–2022). Current limitations of using peroral iron salts (malabsorption, poor adherence to treatment due to gastrointestinal adverse reactions, risks of oxidative stress, and ferroptosis resulting from iron overload) were prerequisites for developing innovative technology, Lipofer®. Lipofer® is a micronized and microencapsulated iron in a phospholipid coat which provides better absorption independent of hepcidin status and targeted iron delivery in tissues with minimization of adverse reaction risks. Limitations of using folic acid include low bioavailability in polymorphisms of folate cycle enzymes (dihydrofolate reductase/DHFR and methylenetetrahydrofolate reductase/MTHFR) which results in potential toxic effects of unmetabolized folic acid and abnormal homocysteine clearance (risk factors for vascular disorders and B12-deficiency anemia masking). These entities were prerequisites for the development of Quatrefolic®. Quatrefolic® is the glucosamine salt of (6S)-5-methyltetrahydrofolate, an active metabolite of folic acid with high solubility and bioavailability ready to enter the folate cycle without involving reductases. Quatrefolic® is safe and has no risks of overdosing or effects on B12-deficiency anemia diagnosis. A combination of two high-tech molecules is an innovative therapeutic tool for essential microelement requirements in women with high risks of iron and folic acid deficiencies. KEYWORDS: iron-deficiency anemia, ferric pyrophosphate, microencapsulated iron, liposomal form, Lipofer, neural tube defect, folic acid, polymorphism, Quatrefolic, glucosamine salt. FOR CITATION: Kononova I.N., Kareva E.N. Fourth-generation folic acid active metabolite Quatrefolic® and micronized, microencapsulated iron Lipofer®: innovative approaches for iron and folic acid deficiencies in women (a review). Russian Journal of Woman and Child Health. 2022;5(1):18–27 (in Russ.). DOI: 10.32364/2618-8430-2022-5-1-18-27.
{"title":"Fourth-generation folic acid active metabolite Quatrefolic® and micronized, microencapsulated iron Lipofer®: innovative approaches for iron and folic acid deficiencies in women (a review)","authors":"I. N. Kononova, E. Kareva, Y. Dobrokhotova","doi":"10.32364/2618-8430-2022-5-1-18-27","DOIUrl":"https://doi.org/10.32364/2618-8430-2022-5-1-18-27","url":null,"abstract":"To review up-to-date management algorithms for iron and folic acid deficiency in women of reproductive age, we selected relevant publications in the PubMed and Google Scholar databases (2012–2022). Current limitations of using peroral iron salts (malabsorption, poor adherence to treatment due to gastrointestinal adverse reactions, risks of oxidative stress, and ferroptosis resulting from iron overload) were prerequisites for developing innovative technology, Lipofer®. Lipofer® is a micronized and microencapsulated iron in a phospholipid coat which provides better absorption independent of hepcidin status and targeted iron delivery in tissues with minimization of adverse reaction risks. Limitations of using folic acid include low bioavailability in polymorphisms of folate cycle enzymes (dihydrofolate reductase/DHFR and methylenetetrahydrofolate reductase/MTHFR) which results in potential toxic effects of unmetabolized folic acid and abnormal homocysteine clearance (risk factors for vascular disorders and B12-deficiency anemia masking). These entities were prerequisites for the development of Quatrefolic®. Quatrefolic® is the glucosamine salt of (6S)-5-methyltetrahydrofolate, an active metabolite of folic acid with high solubility and bioavailability ready to enter the folate cycle without involving reductases. Quatrefolic® is safe and has no risks of overdosing or effects on B12-deficiency anemia diagnosis. A combination of two high-tech molecules is an innovative therapeutic tool for essential microelement requirements in women with high risks of iron and folic acid deficiencies. KEYWORDS: iron-deficiency anemia, ferric pyrophosphate, microencapsulated iron, liposomal form, Lipofer, neural tube defect, folic acid, polymorphism, Quatrefolic, glucosamine salt. FOR CITATION: Kononova I.N., Kareva E.N. Fourth-generation folic acid active metabolite Quatrefolic® and micronized, microencapsulated iron Lipofer®: innovative approaches for iron and folic acid deficiencies in women (a review). Russian Journal of Woman and Child Health. 2022;5(1):18–27 (in Russ.). DOI: 10.32364/2618-8430-2022-5-1-18-27.","PeriodicalId":34075,"journal":{"name":"RMZh Mat'' i ditia","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69548164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.32364/2618-8430-2022-5-1-5-10
A. Zagarskikh, E. Butina, G. Zaytseva
Aim: to study immunogenetic patterns of couples who have appealed to assisted reproductive technologies (ARTs). Patients and Methods: HLA class II typing was performed in 345 couples with different outcomes of ARTs, i.e., ineffective in vitro fertilization (IVF) or intrauterine insemination (IUI), and missed miscarriage after IVF. Inclusion criteria were primary or secondary ART implantation failures. HLA class II typing was performed by real-time PCR. In addition, HLA genotypes were investigated in women examined for female infertility (ICD-10 cone N97) and men examined for urogenital infections plus spermogram, MAR test, and assessment of AZF deletions. All participants were divided into five groups of pairs based on obstetric and gynecologic history, i.e., one failed IVF attempt (n=100), two failed IVF attempts (n=64), three or more failed IVF attempts (n=87), ineffective IUI (n=48), and missed miscarriage after IVF (n=10). The comparision group included 36 couples with one or more childbirths after ARTs. Results: ART efficacy depends on the HLA genotypes of couples. In women, DQA1*01:02 is associated with IVF failure. In men, DQA1*01:01 is associated with failed ART, and DQA1*05:01 is associated with childbirth after ARTs. In men, DRB1*11 favors effective IUI. DQB1*03:03 in women and DRB1*01, DQA1*01:01, and DQB1*05:01 in men predispose to missed miscarriages after IVF and IUI. In men, DQB1*02:01 contributes to childbirths after ARTs. The outcomes of IVF and IUI are not related to husband-wife matching for HLA class II alleles. Conclusion: HLA class II typing is crucial for diagnosing infertility when using assisted reproductive technologies. KEYWORDS: infertility, in vitro fertilization, alleles, genes, HLA. FOR CITATION: Zagarskikh A.N., Butina E.V., Zaytseva G.A. HLA class II alleles in couples with failed ART attempts. Russian Journal of Woman and Child Health. 2022;5(1):5–10 (in Russ.). DOI: 10.32364/2618-8430-2022-5-1-5-10.
{"title":"HLA class II alleles in couples with failed ART attempts","authors":"A. Zagarskikh, E. Butina, G. Zaytseva","doi":"10.32364/2618-8430-2022-5-1-5-10","DOIUrl":"https://doi.org/10.32364/2618-8430-2022-5-1-5-10","url":null,"abstract":"Aim: to study immunogenetic patterns of couples who have appealed to assisted reproductive technologies (ARTs). Patients and Methods: HLA class II typing was performed in 345 couples with different outcomes of ARTs, i.e., ineffective in vitro fertilization (IVF) or intrauterine insemination (IUI), and missed miscarriage after IVF. Inclusion criteria were primary or secondary ART implantation failures. HLA class II typing was performed by real-time PCR. In addition, HLA genotypes were investigated in women examined for female infertility (ICD-10 cone N97) and men examined for urogenital infections plus spermogram, MAR test, and assessment of AZF deletions. All participants were divided into five groups of pairs based on obstetric and gynecologic history, i.e., one failed IVF attempt (n=100), two failed IVF attempts (n=64), three or more failed IVF attempts (n=87), ineffective IUI (n=48), and missed miscarriage after IVF (n=10). The comparision group included 36 couples with one or more childbirths after ARTs. Results: ART efficacy depends on the HLA genotypes of couples. In women, DQA1*01:02 is associated with IVF failure. In men, DQA1*01:01 is associated with failed ART, and DQA1*05:01 is associated with childbirth after ARTs. In men, DRB1*11 favors effective IUI. DQB1*03:03 in women and DRB1*01, DQA1*01:01, and DQB1*05:01 in men predispose to missed miscarriages after IVF and IUI. In men, DQB1*02:01 contributes to childbirths after ARTs. The outcomes of IVF and IUI are not related to husband-wife matching for HLA class II alleles. Conclusion: HLA class II typing is crucial for diagnosing infertility when using assisted reproductive technologies. KEYWORDS: infertility, in vitro fertilization, alleles, genes, HLA. FOR CITATION: Zagarskikh A.N., Butina E.V., Zaytseva G.A. HLA class II alleles in couples with failed ART attempts. Russian Journal of Woman and Child Health. 2022;5(1):5–10 (in Russ.). DOI: 10.32364/2618-8430-2022-5-1-5-10.","PeriodicalId":34075,"journal":{"name":"RMZh Mat'' i ditia","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69548828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.32364/2618-8430-2022-5-1-90-96
L. M. Shchugareva, O. Poteshkina, V. Petrova, P.A. Salamanov
Worster-Drought syndrome (WDS) is a rare neurological disorder characterized by dissociation of voluntary and involuntary movements of the face, mouth, tongue, dysarthria, and oromotor dyspraxia. WDS rate varies from 1–9 per 100,000 to 1 per 25,000–30,000 newborns. Anterior (frontal) operculum, including the lower Rolandic area. WDS is diagnosed in the neonatal period based on a typical phenotype and neuroimaging findings. The prognosis is determined by medical care, epilepsy management, and rehabilitation. We describe a child with a severe WDS phenotype. In this child, abnormal intrauterine neuronal migration was associated with established cytomegalovirus meningoencephalitis in the neonatal period. Moreover, phenotypic signs (dissociation of voluntary and involuntary movements, dysarthria, severe salivation, microcephaly, and epilepsy) were coupled with neuroimaging findings (bilateral polymicrogyria of the opercular area and microcephalia). Pediatricians should be aware of WDS clinical polymorphism. The knowledge base is upgraded annually. KEYWORDS: Worster-Drought syndrome, congenital pseudobulbar palsy, seizures, dysarthria, developmental delay, microcephalia, polymicrogyria. FOR CITATION: Shchugareva L.M., Poteshkina O.V., Petrova V.D., Salamanov P.A. Worster-Drought syndrome. Neurological pattern (case report). Russian Journal of Woman and Child Health. 2022;5(1):90–96 (in Russ.). DOI: 10.32364/2618-8430-2022-5-1-90-96.
{"title":"Worster-Drought syndrome. Neurological pattern (case report)","authors":"L. M. Shchugareva, O. Poteshkina, V. Petrova, P.A. Salamanov","doi":"10.32364/2618-8430-2022-5-1-90-96","DOIUrl":"https://doi.org/10.32364/2618-8430-2022-5-1-90-96","url":null,"abstract":"Worster-Drought syndrome (WDS) is a rare neurological disorder characterized by dissociation of voluntary and involuntary movements of the face, mouth, tongue, dysarthria, and oromotor dyspraxia. WDS rate varies from 1–9 per 100,000 to 1 per 25,000–30,000 newborns. Anterior (frontal) operculum, including the lower Rolandic area. WDS is diagnosed in the neonatal period based on a typical phenotype and neuroimaging findings. The prognosis is determined by medical care, epilepsy management, and rehabilitation. We describe a child with a severe WDS phenotype. In this child, abnormal intrauterine neuronal migration was associated with established cytomegalovirus meningoencephalitis in the neonatal period. Moreover, phenotypic signs (dissociation of voluntary and involuntary movements, dysarthria, severe salivation, microcephaly, and epilepsy) were coupled with neuroimaging findings (bilateral polymicrogyria of the opercular area and microcephalia). Pediatricians should be aware of WDS clinical polymorphism. The knowledge base is upgraded annually. KEYWORDS: Worster-Drought syndrome, congenital pseudobulbar palsy, seizures, dysarthria, developmental delay, microcephalia, polymicrogyria. FOR CITATION: Shchugareva L.M., Poteshkina O.V., Petrova V.D., Salamanov P.A. Worster-Drought syndrome. Neurological pattern (case report). Russian Journal of Woman and Child Health. 2022;5(1):90–96 (in Russ.). DOI: 10.32364/2618-8430-2022-5-1-90-96.","PeriodicalId":34075,"journal":{"name":"RMZh Mat'' i ditia","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69549008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.32364/2618-8430-2022-5-2-112-117
A. N. Mal’tseva
Aim: to assess the effect of the COVID-19 infection on the menstrual function in women of reproductive age. Patients and Methods: the study group included 20 women who experienced COVID-19 and presented with menstrual disorders after infection. The study group was divided into two subgroups, i.e., women with mild (n=10) or severe (n=10) COVID-19 infection (subgroups 1 and 2, respectively). The control group included ten women without a history of COVID-19 infection and menstrual disorders. Hormone levels and hemostasis were evaluated, Doppler ultrasound (US) of basal and spiral arteries and ovarian arteries was performed in all women. Results: the mean age was 28.5±1.28 years in both groups. The period duration was 28.3±1.21 days in the control group and 53.1±0.84 days in the study group (i.e., 1.9-times greater, p<0.05). The rate of ovulatory cycles was 100% in the study group. The rate of anovulatory cycles was 25.8% in subgroup 1 and 77.8% in subgroup 2. Endometrial thickness (by US) was 10.64 [10.4; 11.1] mm in the control group, 6.31 [6.12; 6.87] mm in subgroup 1 and 3.20 [3.12; 3.45] mm in subgroup 2 (p<0.05). Significant abnormalities in hormone levels, endometrial hemodynamics, and hemogram parameters were detected in the study group compared to the control group. Moreover, in women with severe COVID-19 infection, these abnormalities were much more significant. Conclusion: in women of reproductive age who experienced COVID-19 infection, menstrual disorders were revealed based on hormone levels, hemostasis, and pelvic hemodynamics. KEYWORDS: coronavirus infection, COVID-19, menstrual function, reproductive period, Doppler ultrasound, hemodynamics, thrombosis, hemostasis. FOR CITATION: Mal’tseva A.N. Effect of the COVID-19 infection on the menstrual function in women of reproductive age. Russian Journal of Woman and Child Health. 2022;5(2):112–117 (in Russ.). DOI: 10.32364/2618-8430-2022-5-2-112-117.
{"title":"Effect of the COVID-19 infection on the menstrual function in women of reproductive age","authors":"A. N. Mal’tseva","doi":"10.32364/2618-8430-2022-5-2-112-117","DOIUrl":"https://doi.org/10.32364/2618-8430-2022-5-2-112-117","url":null,"abstract":"Aim: to assess the effect of the COVID-19 infection on the menstrual function in women of reproductive age. Patients and Methods: the study group included 20 women who experienced COVID-19 and presented with menstrual disorders after infection. The study group was divided into two subgroups, i.e., women with mild (n=10) or severe (n=10) COVID-19 infection (subgroups 1 and 2, respectively). The control group included ten women without a history of COVID-19 infection and menstrual disorders. Hormone levels and hemostasis were evaluated, Doppler ultrasound (US) of basal and spiral arteries and ovarian arteries was performed in all women. Results: the mean age was 28.5±1.28 years in both groups. The period duration was 28.3±1.21 days in the control group and 53.1±0.84 days in the study group (i.e., 1.9-times greater, p<0.05). The rate of ovulatory cycles was 100% in the study group. The rate of anovulatory cycles was 25.8% in subgroup 1 and 77.8% in subgroup 2. Endometrial thickness (by US) was 10.64 [10.4; 11.1] mm in the control group, 6.31 [6.12; 6.87] mm in subgroup 1 and 3.20 [3.12; 3.45] mm in subgroup 2 (p<0.05). Significant abnormalities in hormone levels, endometrial hemodynamics, and hemogram parameters were detected in the study group compared to the control group. Moreover, in women with severe COVID-19 infection, these abnormalities were much more significant. Conclusion: in women of reproductive age who experienced COVID-19 infection, menstrual disorders were revealed based on hormone levels, hemostasis, and pelvic hemodynamics. KEYWORDS: coronavirus infection, COVID-19, menstrual function, reproductive period, Doppler ultrasound, hemodynamics, thrombosis, hemostasis. FOR CITATION: Mal’tseva A.N. Effect of the COVID-19 infection on the menstrual function in women of reproductive age. Russian Journal of Woman and Child Health. 2022;5(2):112–117 (in Russ.). DOI: 10.32364/2618-8430-2022-5-2-112-117.","PeriodicalId":34075,"journal":{"name":"RMZh Mat'' i ditia","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69549123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-01DOI: 10.32364/2618-8430-2022-5-2-173-177
A. S. Bevz, T. A. Bokova, L. M. Elin
Gastrointestinal foreign bodies (FB) are a relevant issue of present-day pediatrics due to non-specific clinical presentations, difficulties in collecting medical history because of child’s age, and low awareness of parents and practitioners. The authors describe a 5-year girl with multiple gastric FBs (a conglomeration of hundred 0.3-cm magnetic balls). The girl was twice admitted to different hospitals with different incoming diagnoses. Non-specific clinical symptoms and complaints resulted in late diagnosis, primary exclusion of other infectious (acute gastroenteritis) and inflammatory (ulcerative colitis) GI disorders, and unreasonable prescription of medications including antibiotics. The authors address the management strategy for gastric magnetic FBs in this child and difficulties with their endoscopic removal. More than three weeks (24 days) had passed from the first symptoms to the final diagnosis. This case report illustrates the need for the accurate collection of medical history and timely diagnostic search using X-ray and endoscopic imaging irrespective of a child’s age. KEYWORDS: foreign bodies, gastrointestinal tract, children, magnetic balls, endoscopy, X-ray. FOR CITATION: Bevz A.S., Bokova T.A., Elin L.M. Gastric foreign bodies in a 5-year child: pattern of clinical presentations (case report). Russian Journal of Woman and Child Health. 2022;5(2):173–177 (in Russ.). DOI: 10.32364/2618-8430-2022-5-2-173-177.
{"title":"Gastric foreign bodies in a 5-year child: pattern of clinical presentations (case report)","authors":"A. S. Bevz, T. A. Bokova, L. M. Elin","doi":"10.32364/2618-8430-2022-5-2-173-177","DOIUrl":"https://doi.org/10.32364/2618-8430-2022-5-2-173-177","url":null,"abstract":"Gastrointestinal foreign bodies (FB) are a relevant issue of present-day pediatrics due to non-specific clinical presentations, difficulties in collecting medical history because of child’s age, and low awareness of parents and practitioners. The authors describe a 5-year girl with multiple gastric FBs (a conglomeration of hundred 0.3-cm magnetic balls). The girl was twice admitted to different hospitals with different incoming diagnoses. Non-specific clinical symptoms and complaints resulted in late diagnosis, primary exclusion of other infectious (acute gastroenteritis) and inflammatory (ulcerative colitis) GI disorders, and unreasonable prescription of medications including antibiotics. The authors address the management strategy for gastric magnetic FBs in this child and difficulties with their endoscopic removal. More than three weeks (24 days) had passed from the first symptoms to the final diagnosis. This case report illustrates the need for the accurate collection of medical history and timely diagnostic search using X-ray and endoscopic imaging irrespective of a child’s age. KEYWORDS: foreign bodies, gastrointestinal tract, children, magnetic balls, endoscopy, X-ray. FOR CITATION: Bevz A.S., Bokova T.A., Elin L.M. Gastric foreign bodies in a 5-year child: pattern of clinical presentations (case report). Russian Journal of Woman and Child Health. 2022;5(2):173–177 (in Russ.). DOI: 10.32364/2618-8430-2022-5-2-173-177.","PeriodicalId":34075,"journal":{"name":"RMZh Mat'' i ditia","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69549628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：